SWOG S1505: Results of perioperative chemotherapy (peri-op CTx) with mfolfirinox versus gemcitabine/nab-paclitaxel (Gem/nabP) for resectable pancreatic ductal adenocarcinoma (PDA).
化疗
胰腺癌
新辅助治疗
紫杉醇
作者
Davendra Sohal,Mai T. Duong,Syed A. Ahmad,Namita S. Gandhi,Muhammad Shaalan Beg,Andrea Wang-Gillam,James L. Wade,E. G. Chiorean,Katherine A. Guthrie,Andrew M. Lowy,Philip A. Philip,Howard S. Hochster
4504Background: Clinical outcomes after curative treatment of resectable PDA remain suboptimal. To assess the potential of early control of systemic disease with multiagent peri-op CTx, we conducte...